I/UCRC: BioMolecular Interaction Technology Center

I/UCRC：生物分子相互作用技术中心

• 批准号: 0119825
• 负责人: Thomas Laue
• 金额: $ 35万
• 依托单位: University of New Hampshire
• 依托单位国家: 美国
• 项目类别: Continuing Grant
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-09-01 至 2010-08-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0119825&HistoricalAwards=false
• 关键词: UCRC; BioMolecular; Interaction; Technology; Center

The pharmaceutical and biotechnology industries play a vital role in maintaining and promoting a healthy population, and constitute a major sector of the US economy. These industries have evolved from the empirical treatment of disease to a sophisticated approach for drug development which requires a deeper understanding of the biochemistry of life processes. As a consequence, the accurate description of biomolecular interactions has become a central element in understanding disease mechanisms, and now is an essential ingredient for devising safe and effective pharmaceuticals. A variety of instruments and methods are used to characterize biomolecular interactions. This I/UCRC will enable pharmaceutical and biotechnological, and instrumentation companies to work together toward the development of advanced technologies for characterizing molecular interactions.

制药和生物技术行业在维持和促进人口健康方面发挥着至关重要的作用，是美国经济的主要部门。 这些行业已经从疾病的经验治疗发展为复杂的药物开发方法，这需要对生命过程的生物化学有更深入的了解。 因此，生物分子相互作用的准确描述已成为理解疾病机制的核心要素，现在也是设计安全有效的药物的重要组成部分。 多种仪器和方法用于表征生物分子相互作用。 该 I/UCRC 将使制药和生物技术以及仪器公司能够共同努力开发表征分子相互作用的先进技术。